You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Antimicrobial stewardship

Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections

  • Health technology evaluation
  • Reference number: HTE1
  • Published:  17 August 2022
  • Guidance
  • Tools and resources
  • Information for the public
  • History

the 2018 report from the Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU): Rothery et al. ‘Framework for value assessment of new antimicrobials. Implications of alternative funding arrangements for NICE Appraisal

 

  • Equality impact assessment (MSWord 20 KB)

    Published:
    03 February 2021
  • Final protocol (MSWord 385 KB)

    Published:
    03 March 2021
  • Final protocol Addendum: updated PICO tables (MSWord 22 KB)

    Published:
    03 March 2021
  • Final scope (MSWord 40 KB)

    Published:
    03 February 2021
  • Stakeholder list : Final (MSWord 23 KB)

    Published:
    03 February 2021
  • NICE’s response to comments on draft scope (MSWord 95 KB)

    Published:
    09 February 2021
  • Supporting documentation : Evaluation framework (PDF 204 KB)

    Published:
    09 August 2021
  • Supporting documentation : Antimicrobials evaluation committee: membership (MSWord 44 KB)

    Published:
    09 August 2021

This page was last updated: 13 February 2024

Back to top